Full Press Release Details
Bristol Myers Squibb Announces Virtual 2020 Annual Meeting of Shareholders
NEW YORK - April 14, 2020 - Bristol Myers Squibb (NYSE: BMY) today announced that the Company will hold its 2020 Annual Meeting of Shareholders in a virtual-only format due
to public health concerns relating to the coronavirus (COVID-19) and to protect the health and well-being of its shareholders, directors, employees and the public. As previously announced, the 2020 Annual Meeting will be held on May 5, 2020, at 10:00
Shareholders will not be able to attend the 2020 Annual Meeting in-person at a physical location. However, the virtual 2020 Annual Meeting will provide shareholders of
record as of the close of business on March 16, 2020, the ability to participate, vote their shares and ask questions during the meeting via audio webcast.
To be admitted to the virtual 2020 Annual Meeting, shareholders should visit www.virtualshareholdermeeting.com/BMY2020
and enter the 16-digit control number included on your Important Notice Regarding the Availability of Proxy Materials, on your proxy card, or on the instructions that accompanied your proxy materials.
Guests may join the virtual 2020 Annual Meeting in a listen-only mode. No control number is required.
Below are additional details on how shareholders can participate in the virtual 2020 Annual Meeting:
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious
Twitter, YouTube, Facebook,
Bristol Myers Squibb Contacts